Darifenacin

Enablex

15MG BASE, 7.5MG BASE tablet, extended releaseVereinigte StaatenNicht im HandelZugelassen am 22. Dez. 2004

In anderen Ländern

Dieselben Wirkstoffe in anderen Registern, dieselbe Marke zuerst.

EnablexBrasilien · Aspen Pharma Indústria Farmacêutica LtdaGleiche Marke
EnablexBrasilien · Novartis Biociencias S.AGleiche Marke
EnablexKanada · 15 MG · Tablet (Extended-Release) · Searchlight Pharma INCGleiche Marke
EnablexKanada · 7.5 MG · Tablet (Extended-Release) · Searchlight Pharma INCGleiche Marke
Enablex 15MG Prolonged Release TabletsSaudi-Arabien · NovartisGleiche Marke
Enablex 15MG Prolonged Release TabletsSaudi-Arabien · ASPEN Bad Oldesloe GmbHGleiche Marke
Enablex 7.5MG Prolonged Release TabletsSaudi-Arabien · NovartisGleiche Marke

Packung	Code	Status
DARIFENACIN HYDROBROMIDE EQ 15MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA021513-002	Discontinued
DARIFENACIN HYDROBROMIDE EQ 7.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA021513-001	Discontinued